Mouse Models to Study Von Willebrand Factor in Hemostasis: A Scoping Review
Thrombosis and Haemostasis · 06.09.2026
DOI: 10.1055/a-2941-2718 ↗Kurz gefasst
Scoping Review in der Zeitschrift Thrombosis and Haemostasis, erschienen am 06.09.2026. Verfasst von Veronica DeYoung und 11 weiteren Autor:innen. Beteiligte Einrichtung: Queen's University, Department of Medicine, Ontario, Canada, Kingston. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Von Willebrand factor (VWF) and its primary molecular regulator, ADAMTS13, play an important role in hemostasis. Their dysfunction has been increasingly linked to numerous bleeding, thrombotic, and inflammatory conditions. Murine bleeding models are widely used to study their role and assess therapeutic efficacy of targeted agents. Despite this, no review has systematically identified and compared bleeding models proven to involve VWF or ADAMTS13 in vivo. This scoping review addresses this gap by identifying models, associated outcomes, and evaluating methodological inconsistencies that may impact translatability. A comprehensive literature search was conducted to identify studies using murine models of hemostasis from inception to October 2024. Two reviewers independently screened articles and extracted data on mouse characteristics, bleeding induction methods, and VWF or ADAMTS13-related findings. A total of 35 studies published between 1997 and 2024 were included; 40.0% utilized C57BL/6J mice and 40.0% of models used both sexes. Fourteen (40.0%) studies did not report the mouse supplier, and 20.0 and 80.0% did not report the age and weight of mice, respectively. Most studies (91.4%) used the tail tip transection model, 5.7% employed saphenous vein bleed, and 5.7% performed tail vein transection. Key methodological variations pertained to bleeding quantification, maximum observation time, and length of tail tip removed. This review highlights that most studies assessing VWF-related hemostasis use a single model, but there is methodological variability, limiting reproducibility and translational relevance. Standardized protocols and collaborative efforts to establish consensus guidelines are urgently needed to improve cross-study comparisons to strengthen preclinical therapeutic testing.
Autor:innen und Institutionen
- Queen's University, Department of Medicine, Ontario, Canada, Kingston.
- Thrombosis and Atherosclerosis Research Institute (TaARI), Ontario, Canada, Hamilton.
- Faculty of Health Sciences, McMaster University, Department of Medicine, Ontario, Canada, Hamilton.
- Hamilton Health Sciences, Ontario, Canada, Hamilton.
ORCID-Profile: Veronica DeYoung
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
DeYoung, V., Masood, H., Andrisani, P., Kodeeswaran, A., Arora, J., Sparring, T., Savic, N., Babulic, J. L., Liaw, P. C., Matino, D., Fox-Robichaud, A., & Kretz, C. A. (2026). Mouse Models to Study Von Willebrand Factor in Hemostasis: A Scoping Review. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2941-2718
Vancouver
DeYoung V, Masood H, Andrisani P, Kodeeswaran A, Arora J, Sparring T, et al. Mouse Models to Study Von Willebrand Factor in Hemostasis: A Scoping Review. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2941-2718
BibTeX
@article{DeYoung2026,
author = {DeYoung, Veronica and Masood, Hassan and Andrisani, Peter and Kodeeswaran, Arthane and Arora, Jaskirat and Sparring, Taylor and Savic, Natasha and Babulic, Jonathan L and Liaw, Patricia C and Matino, Davide and Fox-Robichaud, Alison and Kretz, Colin A},
title = {Mouse Models to Study Von Willebrand Factor in Hemostasis: A Scoping Review},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2941-2718}
}
EUVIMED